GLP-1 weight loss drugs set to reshape UK red meat demand

The rapid rise of GLP-1 weight-loss drugs is creating both challenges and opportunities for red meat, according to new analysis from AHDB.

GLP‑1 medications were first developed to treat type 2 diabetes and obesity. They work by reducing appetite, slowing digestion and altering taste perception.

As a result, users tend to eat less food overall and choose smaller portions. Many also look for food that offers more nutrition, especially protein.

The YouGov/AHDB tracker February 2026 found that:

• 85% of GLP-1 users report eating less food overall
• 43% say they are eating more protein-dense foods such as meat and fish

Vanessa Adamson, Retail and Consumer Insight Manager at AHDB, said:

“GLP‑1 drugs are driving a clear shift towards ‘less but better’ eating. Although consumers may buy smaller quantities, protein remains central to their diets.

“Research suggests many are willing to spend more on high‑quality meat when they do buy it.”

Although overall food consumption is lower, protein continues to play a key role in the diet. This creates an opportunity for red meat, particularly:

• Lean cuts
• Nutrient-dense options
• Premium products such as steaks and pork tenderloin

These products fit well with the needs of GLP-1 users, who are looking for foods that support satiety and muscle health.

Evidence from international research supports this trend.

A large US food-demand study found that while GLP‑1 users reduce how much they eat, they’re often more willing to pay for high‑quality meat and seafood.

This suggests a potential shift towards premium products, rather than complete avoidance.

GLP‑1 users report cutting back most on:

• Ultra‑processed foods
• High-calorie foods
• Takeaways

This may pose a challenge for processed meat products and some out‑of‑home channels. At the same time, it strengthens demand for more natural, less processed protein sources.

Retailers are already adapting by offering smaller‑portion, nutrient‑dense meal options.

These changes could also support red meat, especially where products offer convenience, portion control and strong protein credentials.

Vanessa added:

“Red meat is well placed to remain part of a balanced diet for GLP‑1 users, particularly where messaging focuses on lean cuts, quality and nutritional value.

“The key will be meeting changing consumer needs with the right products, portions and communication.”